Amalgamated Bank’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $970K | Buy |
17,543
+605
| +4% | +$33.5K | 0.01% | 1052 |
|
|
2025
Q1 | $819K | Sell |
16,938
-467
| -3% | -$22.6K | 0.01% | 1098 |
|
|
2024
Q4 | $672K | Buy |
17,405
+81
| +0.5% | +$3.13K | 0.01% | 1198 |
|
|
2024
Q3 | $780K | Buy |
17,324
+15,301
| +756% | +$689K | 0.01% | 1139 |
|
|
2024
Q2 | $70K | Buy |
2,023
+74
| +4% | +$2.56K | ﹤0.01% | 1789 |
|
|
2024
Q1 | $56K | Sell |
1,949
-4,912
| -72% | -$141K | ﹤0.01% | 1842 |
|
|
2023
Q4 | $157K | Buy |
6,861
+100
| +1% | +$2.29K | ﹤0.01% | 1870 |
|
|
2023
Q3 | $113K | Hold |
6,761
| – | – | ﹤0.01% | 1957 |
|
|
2023
Q2 | $187K | Buy |
6,761
+2,032
| +43% | +$56.2K | ﹤0.01% | 1841 |
|
|
2023
Q1 | $109K | Sell |
4,729
-1,036
| -18% | -$23.9K | ﹤0.01% | 2025 |
|
|
2022
Q4 | $63K | Hold |
5,765
| – | – | ﹤0.01% | 2326 |
|
|
2022
Q3 | $49K | Hold |
5,765
| – | – | ﹤0.01% | 2471 |
|
|
2022
Q2 | $46K | Sell |
5,765
-1,530
| -21% | -$12.2K | ﹤0.01% | 2531 |
|
|
2022
Q1 | $173K | Sell |
7,295
-584
| -7% | -$13.8K | ﹤0.01% | 1995 |
|
|
2021
Q4 | $269K | Buy |
+7,879
| New | +$269K | ﹤0.01% | 1868 |
|
|
2021
Q3 | – | Sell |
-7,807
| Closed | -$350K | – | 2177 |
|
|
2021
Q2 | $350K | Buy |
+7,807
| New | +$350K | ﹤0.01% | 1810 |
|